Oral Azithromycin Versus Doxycycline in Posterior Blepharitis
Posterior Blepharitis
About this trial
This is an interventional treatment trial for Posterior Blepharitis focused on measuring Azithromycin, Doxycycline, Posterior Blepharitis
Eligibility Criteria
Inclusion Criteria:
Patients were diagnosed with posterior blepharitis if they scored at least one in two symptoms (based on a subjective grading scale) and two signs (based on an objective grading scale) of posterior blepharitis according to study criteria
Exclusion Criteria:
Patients were excluded if they had the following criteria: age< 12 years old,history of previous ocular or lacrimal surgery,previous usage of contact lenses,any history of ocular allergy,history of systemic diseases with ocular involvement (except rosacea), history of usage of topical or systemic antibiotic in the last month, pregnancy or lactating mothers, liver failure and any history of sensitivity to cyclines
Sites / Locations
- Rassoul Akram Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Oral Azithromycin
Doxycycline
Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.
Oral doxycycline 100mg capsule every 12 hours for one month